Article by Max Schindler, The Jerusalem Post
The Health Ministry recently gave its stamp of approval to an Israeli company producing marijuana vaporizers, possibly becoming the first country in the world to certify such a device for medical purposes.
Tel Aviv-based Kanabo Research, a medical-cannabis R&D firm, announced on Tuesday that the ministry certified the company’s VapePod vaporizer for the use of medical cannabis extracts and formulations.
“This approval is a significant announcement for the medical cannabis patients in Israel who will be able to use the medical vaporizer for the first time,” said Avihu Tamir, Kanabo’s co-founder and CEO.
Administering cannabis to patients has long frustrated doctors due to the lack of a precise dosage. It’s a problem that Kanabo says it can circumvent with the VapePod’s consistent and accurate gauge.
Founded in 2016, Kanabo employs 12 people. The firm expects to reach $10 million in sales within three years in the Israeli market, while the overall local cannabis trade could reach revenues of $100m. during that time.
An estimated 50 Israeli medical marijuana companies work in cultivating plants or producing delivery devices such as inhalers, along with exporting cannabis cosmetics and skin-care products. In 2016, international investors poured more than $100m. into Israeli marijuana firms, according to Reuters.
“The Israeli market is a platform to deliver our technology to global markets in North America and Europe,” Tamir added.